LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now
Investing Articles
As AstraZeneca’s share price drops 11%, does the stock look an unmissable bargain to me?
Dividend Shares
Here are the 2025 dividend forecasts for FTSE giants Unilever, GSK, and AstraZeneca
Investing Articles
I wish I’d known about this profitable stock market investing strategy 10 years ago
Investing Articles
2 of my favourite FTSE 100 shares have just plunged 12% and 10%! Time to buy?
Investing Articles
As AstraZeneca’s share price drops 13% should I buy on the dip?
Investing Articles
3 stunning FTSE 100 shares I plan to buy in October
Investing Articles
This UK stock looks pretty cheap to me
Investing Articles
My favourite UK share on the entire LSE has fallen 5% in a week! Time to buy?
Investing Articles
FTSE 100 investors should pay attention to these 4 things in September 2024
Investing Articles
4 stocks that might power the FTSE 100 towards 10,000